Literature DB >> 6881174

Bacteremia due to Fusobacterium species.

S Henry, A DeMaria, W R McCabe.   

Abstract

Twenty-six patients were identified as having bacteremia with Fusobacterium species over a five-year period at Boston City Hospital. They represented 0.9 percent of bacteremic patients and were equally divided as to sex. Bacteremia with Fusobacterium occurred primarily in young adults and in patients over 60 years of age and was not observed in children. In 16 patients (62 percent), Fusobacterium was the only blood culture isolate. The most common primary foci of infection were the female genital tract, the upper respiratory tract, the oral cavity, and the lower respiratory tract. Five patients had primary foci of infection that were initially occult. Three of these patients were found to have unappreciated oral and pharyngeal lesions, and one had a liver abscess; no primary infection was established in the remaining patient. Shock related to bacteremia developed in six patients (23 percent), four of whom had Fusobacterium species as the only blood culture isolate. Death occurred in three patients (12 percent), all of whom were over 60 years old. Metastatic infection occurred in only one patient in whom hematogenous osteomyelitis developed. Postpartum fusobacterial bacteremia was uniformly benign. Evaluation of bacteremia with Fusobacterium species in nonpostpartum patients, without an overt focus of infection, should be directed to a search for occult abscess, especially of the upper respiratory tract and oral cavity.

Entities:  

Mesh:

Year:  1983        PMID: 6881174     DOI: 10.1016/0002-9343(83)91196-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  20 in total

Review 1.  Lemierre's syndrome (necrobacillosis).

Authors:  R Golpe; B Marín; M Alonso
Journal:  Postgrad Med J       Date:  1999-03       Impact factor: 2.401

2.  Necrobacillosis with pancytopenia.

Authors:  M Epstein; A D Pearson; S J Hudson; R Bray; M Taylor; J Beesley
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

3.  From a sore throat to the intensive care unit: the Lemierre syndrome.

Authors:  Maximilian Hochmair; Arschang Valipour; Elisabeth Oschatz; Peter Hollaus; Monika Huber; Otto Chris Burghuber
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

4.  6-phospho-alpha-D-glucosidase from Fusobacterium mortiferum: cloning, expression, and assignment to family 4 of the glycosylhydrolases.

Authors:  C L Bouma; J Reizer; A Reizer; S A Robrish; J Thompson
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

Review 5.  Clindamycin-resistant Fusobacterium varium bacteremia and decubitus ulcer infection.

Authors:  M C Legaria; G Lumelsky; V Rodriguez; S Rosetti
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  Disseminated intravascular coagulation with Fusobacterium necrophorum septicaemia.

Authors:  M N Potter; H C Drysdale; P A Price; A C Buck
Journal:  Postgrad Med J       Date:  1988-02       Impact factor: 2.401

7.  Retrospective analysis of two hundred and twelve cases of bacteremia due to anaerobic microorganisms.

Authors:  E Bouza; M Reig; M Garcia de la Torre; M Rodríguez-Créixems; J Romero; E Cercenado; F Baquero
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

8.  Incidence and clinical epidemiology of necrobacillosis, including Lemierre's syndrome, in Denmark 1990-1995.

Authors:  L H Hagelskjaer; J Prag; J Malczynski; J H Kristensen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

9.  Febrile neutropenia and Fusobacterium bacteremia: clinical experience with 13 cases.

Authors:  P Fanourgiakis; M Vekemans; A Georgala; D Daneau; A Vandermies; P Grenier; M Aoun
Journal:  Support Care Cancer       Date:  2003-03-13       Impact factor: 3.603

10.  Multiple brain abscesses and bacteremia in a child due to Fusobacterium necrophorum.

Authors:  J F Meis; T W Polder; P van de Kar; J A Hoogkamp-Korstanje
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.